High Dose of Tigecycline for Extremely Resistant Gram-Negative Pneumonia: Yes, We Can

Critical Care - United Kingdom
doi 10.1186/cc13942
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Yes, We Can!

Info Diabetologie
2010English

Yes We Can!

International Journal of Computer-Supported Collaborative Learning
EducationHuman-Computer Interaction
2008English

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia

Critical Care
Critical CareIntensive Care Medicine
2019English

Comparative Evaluation of Tigecycline Susceptibility Testing Methods for Expanded-Spectrum Cephalosporin- And Carbapenem-Resistant Gram-Negative Pathogens

Journal of Clinical Microbiology
Microbiology
2012English

Can We Afford Open-Ended ICU Care? Yes We Can, but ...

Critical Care
Critical CareIntensive Care Medicine
2010English

High Prevalence of Antimicrobial-Resistant Gram-Negative Colonization in Hospitalized Cambodian Infants

Pediatric Infectious Disease Journal
Child HealthInfectious DiseasesPediatricsPerinatologyMicrobiology
2016English

Factors Associated With Survival of ICU Patients With Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria

Critical Care
Critical CareIntensive Care Medicine
2015English

Erratum To: Kinase Activity Profiling of Gram-Negative Pneumonia

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2011English

High-Dose Sulbactam Treatment for Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter Baumannii

The Korean Journal of Critical Care Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy